These terms suggest a differential influence of G0S2 on NAFLD by interacting with PNPLA2, ABHD5, E-cadherin, and cell adhesions (2, 38–40). The gene discussed is CDH1; the disease is metabolic dysfunction-associated steatotic liver disease.